Darling Ingredients reports Q1 2026 results Thursday morning, and the setup is unusual: the stock has climbed 4.2% on the week to $62.80, yet earnings reactions over recent quarters have been almost entirely muted.
The most striking feature of the current setup is the relentless analyst re-rating. Every firm that has touched DAR in the past month has raised its price target — without a single downgrade or rating cut. TD Cowen lifted its target from $58 to $72 on Tuesday, maintaining Buy. That followed Scotiabank raising to $70, Stephens to $70, Jefferies to $73, Baird to $75, UBS to $78, and JPMorgan to $69, all in the past four weeks. The consensus mean target is now $72.17, roughly 15% above the current price. What's notable is the character of the moves: these are target increases averaging $10-12 per firm across the board, not incremental tweaks. The Street is repricing the earnings power story, with forward EPS momentum ranking in the 99th percentile of the universe over 90 days and the 97th percentile over 30 days — the kind of sustained estimate revision that typically precedes a step-change in expectations.
Positioning in the lending market tells a story of indifference rather than aggression. Short interest is 4.3% of the free float — enough to be meaningful but not elevated — and the week-on-week rise of 4.4% is the headline number, though it brings shorts back only to late-March levels. Borrow availability is exceptionally loose, far above 1,000% of outstanding short interest, meaning there is effectively no constraint on new shorting. Cost to borrow has edged up to 0.51%, a one-month high, but still firmly in "easy borrow" territory. Days to cover runs at just 2.1 days. In short, there is no squeeze dynamic here and no sign that shorts are under pressure — this is a low-conviction bear camp sitting in a stock that has reacted quietly to recent earnings.
Options data reinforces a marginally more cautious tilt heading into Thursday. The put/call ratio is 0.45, above its 20-day average of 0.38, and earlier this week briefly touched the 52-week high of 0.51. The z-score of 0.96 puts the reading roughly one standard deviation above its recent mean — not alarming, but a clear shift from the strongly bullish options tone seen through most of March, when the PCR was printing in the 0.16-0.20 range. Investors are buying somewhat more downside protection than usual, even as the stock rallies.
On valuation, the re-rating appears well underway. The trailing PE has contracted from around 17.8 to 14.1 over the past 30 days — not because the business is deteriorating but because the stock rally is being outpaced by upward estimate revisions. EV/EBITDA at roughly 8.3x is down almost a full turn on the month. The annual EBITDA estimate is $1.66bn on revenues of $6.63bn, implying margins are recovering from prior-year lows. At $62.80 the stock trades on a forward earnings yield of roughly 7.1%, which on a PE basis puts it at 14x — modest for a business whose EPS revisions are among the most positive in the market. The EV/EBIT spread to EBITDA is notable: the ratio sits near 9 on a percentile basis, flagging a business carrying meaningful D&A relative to operating income, consistent with the capital-intensive rendering and renewable fuels mix.
Earnings history shows the stock barely moves after prints. The last four reported quarters generated 1-day moves of -0.1%, +2.4%, +0.1%, and +2.7% respectively — the largest 5-day follow-through was +4.3%. Thursday's Q1 print is therefore less a volatility event and more a progress report on whether the wave of analyst estimate increases is getting the execution data it needs to hold.
Close peer ADM gained 4.3% on the week, tracking DAR almost tick-for-tick, while Bunge Global added only 0.4% — suggesting the agricultural processing names with the most short-cover or upgrade momentum are outpacing the group. The question after Thursday morning's numbers is whether the target cluster of $70-78 starts to look conservative, or whether the stock runs into its first meaningful resistance since the re-rating began.
See the live data behind this article on ORTEX.
Open DAR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
